http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022238603-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8aeb2d280538a76c8bc83b4fae9b065
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H05H1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H05H1-00
filingDate 2022-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_507a6422a1de2be7c2ea744890dd5d2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11dfc63f0da2696ee74e702170de5fe2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5af744d434575d3fe7a0075f8fe2a97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92fb7ba6742b19ea75a90f4809b6939b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28d9dfe3b9941c8a623a5fe5f9f24da9
publicationDate 2022-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022238603-A1
titleOfInvention Plasma-activated media for use thereof in the treatment of respiratory diseases
abstract The proposed invention relates to plasma-activated liquid media for use thereof in the treatment of diseases, whether viral and/or bacterial (including antibiotic-resistant bacteria), of the upper and lower respiratory tracts in humans and animals. These media exhibit an antiviral and antibacterial activity based on the oxidative stress that they cause in the microorganisms and cells affected by the same. Said oxidative stress is caused by reactive oxygen and nitrogen molecule species dissolved in the plasma-activated medium and is tolerated by the healthy cells, but it inactivates said harmful microorganisms. The proposed use is useful for fighting viral and/or bacterial respiratory infections.
priorityDate 2021-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26894
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44357137
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08317
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49113
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10145
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7YRB5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP79255
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100002946
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID493836
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3576
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ102R3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396880
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41324
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP46653
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9XSX5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426343843
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403850
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36925
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67814
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO62812
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67813
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970

Total number of triples: 49.